Recurrent Rectal Cancer: Clinical Trials

33 trials for Recurrent Rectal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 7 terminated. 33 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 133Completed 26, Terminated 7
Phase 26Completed 5, Terminated 1

Follow Recurrent Rectal Cancer: new trials by email Literature Review of Recurrent Rectal Cancer trials Research Report on Recurrent Rectal Cancer

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver
irinotecan-eluting beads, hepatic artery embolization - Liver Metastases, Mucinous Adenocarcinoma of the Colon
Phase 1TerminatedFox Chase Cancer Center22016-01-292018-02-26
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
6,8-bis(benzylthio)octanoic acid, fluorouracil, pharmacological study - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Phase 1CompletedWake Forest University Health Sciences192015-01-062023-08-07
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer
intensity-modulated radiation therapy, fluorouracil, oxaliplatin - Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer
Phase 1CompletedVirginia Commonwealth University142014-12-042021-07-20
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer
MEK inhibitor MEK162, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedCity of Hope Medical Center262014-07-162026-10-19
Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
irinotecan hydrochloride, alisertib - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Phase 1CompletedUniversity of California, Davis172013-08-012019-01-04
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedSanjiv Sam Gambhir252013-03-042019-10-03
Ipilimumab and Local Radiation for Selected Solid Tumors
Ipilimumab, Radiation therapy - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1TerminatedStanford University32013-02-012024-01-24
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
trametinib, fluorouracil, radiation therapy - Recurrent Rectal Cancer, Stage IIA Rectal Cancer
Phase 1CompletedOhio State University Comprehensive Cancer Center192012-11-262023-09-18
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
selumetinib, cetuximab, laboratory biomarker analysis - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedNational Cancer Institute (NCI)332012-10-012014-05-29
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer
laboratory biomarker analysis, enzyme-linked immunosorbent assay, flow cytometry - Recurrent Colon Cancer, Recurrent Gastric Cancer
Phase 1CompletedCity of Hope Medical Center122011-12-222026-10-19
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
irinotecan hydrochloride, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedCity of Hope Medical Center32011-08-302026-10-16
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
AUY922, Cetuximab - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedSwedish Medical Center202011-02-012015-06-08
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
veliparib, capecitabine, oxaliplatin - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach
Phase 1TerminatedNational Cancer Institute (NCI)162010-10-012014-04-02
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1TerminatedUniversity of Southern California72010-10-012015-05-27
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
irinotecan-eluting beads, hepatic artery embolization - Liver Metastases, Mucinous Adenocarcinoma of the Colon
Phase 1TerminatedFox Chase Cancer Center42010-10-012021-12-20
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
gamma-secretase/Notch signalling pathway inhibitor RO4929097, capecitabine, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Phase 1CompletedNational Cancer Institute (NCI)302010-06-012014-11-07
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
pertuzumab, cetuximab, irinotecan hydrochloride - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)172007-10-012015-03-31
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
cetuximab, erlotinib hydrochloride, laboratory biomarker analysis - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Phase 1CompletedNational Cancer Institute (NCI)432007-01-012015-09-30
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
oxaliplatin, leucovorin calcium, vorinostat - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedNational Cancer Institute (NCI)542005-07-012013-09-30
Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery
gemcitabine hydrochloride, floxuridine, proteomic profiling - Liver Metastases, Recurrent Colon Cancer
Phase 1 / Phase 2CompletedCity of Hope Medical Center162005-06-132026-11-03

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Rectal Neoplasms (33)  ·  Colonic Neoplasms (31)  ·  Pancreatic Neoplasms (10)  ·  Carcinoma, Non-Small-Cell Lung (8)  ·  Breast Neoplasms (7)  ·  Salivary Gland Neoplasms (7)  ·  Stomach Neoplasms (6)  ·  Breast Neoplasms, Male (5)  ·  Carcinoma, Hepatocellular (5)  ·  Esthesioneuroblastoma, Olfactory (5)  ·  Squamous Cell Carcinoma of Head and Neck (5)  ·  Anus Neoplasms (4)  ·  Carcinoma, Ovarian Epithelial (4)  ·  Esophageal Neoplasms (4)  ·  Gallbladder Neoplasms (4)

Broader conditions

Digestive System Diseases (32)  ·  Digestive System Neoplasms (32)  ·  Gastrointestinal Diseases (32)  ·  Intestinal Diseases (32)  ·  Intestinal Neoplasms (32)  ·  Neoplasms by Site (32)  ·  Rectal Diseases (32)  ·  Gastrointestinal Neoplasms (31)  ·  Neoplasms (31)  ·  Colonic Diseases (30)  ·  Colorectal Neoplasms (30)  ·  Endocrine Gland Neoplasms (10)  ·  Endocrine System Diseases (10)  ·  Neoplasms by Histologic Type (10)  ·  Pancreatic Diseases (10)

Interventions

Fluorouracil (9)  ·  Cetuximab (6)  ·  Irinotecan (6)  ·  Leucovorin (6)  ·  Oxaliplatin (6)  ·  Erlotinib Hydrochloride (4)  ·  Bevacizumab (3)  ·  Capecitabine (3)  ·  Gene Expression Profiling (2)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (2)  ·  Radiation (2)  ·  Radiotherapy (2)  ·  sargramostim (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  2C4 antibody (1)

Sponsors

National Cancer Institute (NCI) (19)  ·  City of Hope Medical Center (4)  ·  Fox Chase Cancer Center (2)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Sanjiv Sam Gambhir (1)  ·  Stanford University (1)  ·  Swedish Medical Center (1)  ·  University of California, Davis (1)  ·  University of Southern California (1)  ·  Virginia Commonwealth University (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (33)  ·  Canada (1)

Top investigators

Marwan Fakih (2)  ·  Wells Messersmith (2)  ·  William Schelman (2)  ·  Alain Mita (1)  ·  Antonius Miller (1)  ·  Caio Rocha Lima, MD (1)  ·  Efrat Dotan (1)  ·  Efrat Dotan, MD (1)  ·  Emma C Fields, MD (1)  ·  George A. Fisher, MD, PhD (1)  ·  Heinz-Josef Lenz (1)  ·  James Abbruzzese (1)  ·  Jeffrey Wong (1)  ·  Jeffrey Wong, MD (1)  ·  John Marshall (1)

Results publications

PMID 24987057, PMID 25965900, PMID 26062933, PMID 26611425, PMID 30850872, PMID 33993383

NIH funding

P30CA014520 (3), U01CA062491 (3), U01CA070095 (2), N01CM17003 (1), P30CA006927 (1), P30CA012197 (1), P30CA016059 (1), P30CA044579 (1), P30CA051008 (1), P30CA054174 (1), P30CA068485 (1), P30CA093373 (1), R01CA088972 (1), R21CA117125 (1), U01CA062490 (1)